Funding to support on-site pharmacists in residential aged-care facilities
25 March, 2022The government has announced $345.7m funding for on-site pharmacists and community pharmacy services in government-funded residential aged care facilities (RACFs).
Hospital pharmacists' role in COVID-19 treatments
23 March, 2022 by Kristin Michaels, SHPA Chief ExecutiveThe introduction of oral antiviral treatments calls on the expertise and services of hospital pharmacists as we progress towards the endemic stage of this pandemic.
WA pharmacist recognised for leadership, contribution to medical safety
16 March, 2022Kerry Fitzsimons has been recognised by the Society of Hospital Pharmacists of Australia (SHPA) for her leadership and contribution to medical safety in Western Australia and beyond.
SHPA releases pharmacy standard for heart disease
08 March, 2022The new pharmacy practice standard recommends patient to pharmacist ratios and quality improvement indicators specific to specialist cardiology pharmacists.
Royal Victorian Eye and Ear Hospital implements PSML
07 March, 2022The Royal Victorian Eye and Ear Hospital is said to be the first hospital in Australia to implement the Pharmacist Shared Medicines List medicine safety initiative.
New rare blood disease treatment on PBS
28 February, 2022Ultomiris (ravulizumab) will be listed for the first time for patients with paroxysmal nocturnal haemoglobinuria.
Bill to shore up medicine supplies: SHPA
03 December, 2021The Society of Hospital Pharmacists of Australia (SHPA) has welcomed new federal government legislation to further mitigate the impact of medicine shortages on Australians and ensure new and innovative medicines are accessible, available and affordable.
More expert pharmacists needed in the era of medicine miracles
23 September, 2021 by Kristin Michaels, SHPA Chief ExecutiveAs we live through the lengthening tail of a persistent pandemic, it is challenging to consider the simpler medicines landscape of 20 years ago.
Aus antimicrobial use decreasing but not enough: report
27 August, 2021While antimicrobial use in the community is decreasing, overprescribing and inappropriate prescribing continue to be problematic.
Review of National Medicines Policy after 22 years
04 August, 2021For the first time since its development in 1999, Australia's National Medicines Policy is set for review.
Speed up pharmacy vaccine rollout to end lockdown, says report
21 July, 2021Accelerating the rollout of vaccines into pharmacies could help Australia reach its vaccination target of 80% up to two months faster than current projections.
Medicinal cannabis facility planned for Toowoomba
12 July, 2021Medibis has announced long-term plans to build a multi-million-dollar medicinal cannabis facility in Toowoomba, Queensland.
Metabolic hormone leptin linked to vaccine response
31 May, 2021 by Amy SarcevicReduced levels of the metabolic hormone leptin may be responsible for poor vaccine efficacy among certain individuals, according to a new study.
New COVID-19 vaccine completely blocks viral transmission
19 May, 2021 by Amy SarcevicAn Adelaide-based company has developed a COVID-19 vaccine that completely blocks viral transmission to individuals who lack immunity, as well as offering protection for those inoculated.
Historic PBS listing of cannabis for Dravet syndrome
10 May, 2021Epidyolex has been added to the Pharmaceutical Benefits Scheme (PBS) for the treatment of Dravet syndrome, a rare and drug-resistant form of epilepsy.
